Is Fanapt (iloperidone) considered a controlled substance?
Fanapt (iloperidone) is not classified as a controlled substance in the way drugs like opioids or benzodiazepines are. It does not have the controlled-substance scheduling status associated with drugs that can be prescribed and tracked under U.S. DEA “Schedules” for abuse potential.
What matters legally: DEA schedule vs. “controlled” in other ways
Even when a medication is not a DEA-controlled substance, it can still be “controlled” in practical terms:
- It may require a prescription and careful monitoring by the prescriber.
- It may have restrictions due to safety (for example, heart rhythm concerns such as QT prolongation), which affect prescribing and labeling requirements rather than DEA scheduling.
How to confirm for your location (US vs. other countries)
Controlled-substance status can vary by country. If you want to be 100% sure for where you live, check:
- Your local pharmacy labeling (often indicates whether it’s “controlled” or has a schedule number), or
- Your country’s drug control authority database.
If you’re asking because of refills or pharmacy rules
If a pharmacy treats Fanapt differently, the reason is usually prescription and safety monitoring rules—not DEA controlled-substance handling (like limits on refill count, special ordering, or documented “controlled” dispensing procedures).
Sources
No sources were provided in the prompt, and I can’t verify DEA scheduling details for Fanapt without an external reference. If you share the country (e.g., U.S., Canada, UK) or whether you mean DEA scheduling specifically, I can tailor the answer to that jurisdiction.